Zoetis Inc.
Zoetis Inc. (ZTS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
zts · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Zoetis Inc. (ZTS) measures how much investors pay for each dollar of the company's trailing earnings. ZTS's current PE ratio of 12.69x is calculated by dividing its stock price of $79.44 by its TTM earnings per share of $6.26. −64.5% discount vs 5Y avg 35.8x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2009 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 16 fiscal years · Front-end computedMinQ1 · 25%37.9x
MedianQ3 · 75%134.8x
Max
At 12.69x, ZTS's current P/E is lower than in 0% of its annual fiscal year readings over the past 16 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - General · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Zoetis Inc.You ZTS | $33.3B | 12.69x | -51.2% | $6.26 |
 argenx SE ARGX | $55.6B | 39.90x | +53.4% | $21.08 |
 Becton, Dickinson and Company BDX | $54.2B | 25.13x | -3.3% | $5.85 |
 Cigna Corporation CI | $76.0B | 12.29x | -52.7% | $22.40 |
 Cencora, Inc. COR | $53.1B | 38.98x | +49.9% | $8.02 |
 Elanco Animal Health Incorporated ELAN | $11.8B | N/A | — | -$0.47 |
 Elevance Health Inc. ELV | $89.8B | 13.73x | -47.2% | $25.53 |
Industry Average 5 peers with valid PE | — | 26.00x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 20.87x | $6.03 | -29.9% | |
2024-12-31 FY2024 | 29.77x | $5.47 | -23.3% | |
2023-12-31 FY2023 | 38.83x | $5.08 | +19.5% | |
2022-12-31 FY2022 | 32.51x | $4.51 | -42.8% | |
2021-12-31 FY2021 | 56.83x | $4.29 | +18.3% | |
2020-12-31 FY2020 | 48.04x | $3.44 | +13.9% | |
2019-12-31 FY2019 | 42.19x | $3.14 | +45.8% | |
2018-12-31 FY2018 | 28.94x | $2.96 | -29.2% | |
2017-12-31 FY2017 | 40.85x | $1.76 | +26.4% | |
2016-12-31 FY2016 | 32.32x | $1.66 | -54.2% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Zoetis Inc. (ZTS) measures how much investors pay for each dollar of the company's trailing earnings. ZTS's current PE ratio of 12.69x is calculated by dividing its stock price of $79.44 by its TTM earnings per share of $6.26.
Frequently asked questions
ZTS pe ratio · 6 questionsZTS's current PE ratio is 12.69x as of 2026-06-08, based on a stock price of $79.44 and TTM EPS of $6.26. Data sourced from Financial Modeling Prep via ZTS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Zoetis Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08